Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Depreciation and Depletion (2016 - 2025)

Altimmune (ALT) has disclosed Depreciation and Depletion for 14 consecutive years, with $14000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion fell 57.58% to $14000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Dec 2025, down 57.98% year-over-year, with the annual reading at $100000.0 for FY2025, 57.98% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $14000.0 at Altimmune, down from $27000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $200000.0 in Q4 2021, with the low at $14000.0 in Q4 2025.
  • Average Depreciation and Depletion over 5 years is $81379.4, with a median of $100000.0 recorded in 2021.
  • The sharpest move saw Depreciation and Depletion surged 100.0% in 2021, then crashed 72.9% in 2025.
  • Over 5 years, Depreciation and Depletion stood at $200000.0 in 2021, then tumbled by 50.0% to $100000.0 in 2022, then grew by 14.0% to $114000.0 in 2023, then plummeted by 71.05% to $33000.0 in 2024, then crashed by 57.58% to $14000.0 in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $14000.0, $27000.0, and $30000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.